200,000+ products from a single source!
sales@angenechem.com
202463-68-1 | 1H-Pyrazole-3-carboxamide, 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-4-morpholinyl-
CAS No: 202463-68-1 Catalog No: AG00288Q MDL No:
Product Description
Catalog Number:
AG00288Q
Chemical Name:
1H-Pyrazole-3-carboxamide, 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-4-morpholinyl-
CAS Number:
202463-68-1
Molecular Formula:
C21H19Cl2IN4O2
Molecular Weight:
557.2116
IUPAC Name:
1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-morpholin-4-ylpyrazole-3-carboxamide
InChI:
InChI=1S/C21H19Cl2IN4O2/c1-13-19(21(29)26-27-8-10-30-11-9-27)25-28(18-7-4-15(22)12-17(18)23)20(13)14-2-5-16(24)6-3-14/h2-7,12H,8-11H2,1H3,(H,26,29)
InChI Key:
AJFFBPZYXRNAIC-UHFFFAOYSA-N
SMILES:
Ic1ccc(cc1)c1c(C)c(nn1c1ccc(cc1Cl)Cl)C(=O)NN1CCOCC1
UNII:
SBP4A4DYH2
Properties
Complexity:
589
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
555.993g/mol
Formal Charge:
0
Heavy Atom Count:
30
Hydrogen Bond Acceptor Count:
4
Hydrogen Bond Donor Count:
1
Isotope Atom Count:
0
Molecular Weight:
557.213g/mol
Monoisotopic Mass:
555.993g/mol
Rotatable Bond Count:
4
Topological Polar Surface Area:
59.4A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
5.3
Literature
| Title | Journal |
|---|---|
| The tamoxifen derivative ridaifen-B is a high affinity selective CB(2) receptor inverse agonist exhibiting anti-inflammatory and anti-osteoclastogenic effects. | Toxicology and applied pharmacology 20180612 |
| The synthetic cannabinoid WIN-55,212 induced-apoptosis in cytotrophoblasts cells by a mechanism dependent on CB1 receptor. | Toxicology 20170615 |
| AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: implications for opioid/cannabinoid interaction studies. | Neuropharmacology 20121001 |
| The CB(1) receptor antagonist, AM281, improves recognition loss induced by naloxone in morphine withdrawal mice. | Basic & clinical pharmacology & toxicology 20120901 |
| Estradiol acutely suppresses inhibition in the hippocampus through a sex-specific endocannabinoid and mGluR-dependent mechanism. | Neuron 20120607 |
| Cannabinoid receptor 1 inhibition causes seizures during anesthesia induction in experimental sepsis. | Anesthesia and analgesia 20120601 |
| Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20120516 |
| Hippocampal endocannabinoids play an important role in induction of long-term potentiation and regulation of contextual fear memory formation. | Brain research bulletin 20111010 |
| Cannabinoid receptor agonists modulate oligodendrocyte differentiation by activating PI3K/Akt and the mammalian target of rapamycin (mTOR) pathways. | British journal of pharmacology 20110801 |
| Requirement for the endocannabinoid system in social interaction impairment induced by coactivation of dopamine D1 and D2 receptors in the piriform cortex. | Journal of neuroscience research 20110801 |
| The abused inhalant toluene differentially modulates excitatory and inhibitory synaptic transmission in deep-layer neurons of the medial prefrontal cortex. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20110601 |
| Endocannabinoid modulation of sympathetic and cardiovascular responses to acute stress in the periaqueductal gray of the rat. | American journal of physiology. Regulatory, integrative and comparative physiology 20110301 |
| Effects of drugs of abuse on putative rostromedial tegmental neurons, inhibitory afferents to midbrain dopamine cells. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20110201 |
| Regulation of the hypothalamic-pituitary-adrenal axis circadian rhythm by endocannabinoids is sexually diergic. | Endocrinology 20100801 |
| Expression of cannabinoid CB1 receptors by vagal afferent neurons: kinetics and role in influencing neurochemical phenotype. | American journal of physiology. Gastrointestinal and liver physiology 20100701 |
| GPR55 ligands promote receptor coupling to multiple signalling pathways. | British journal of pharmacology 20100601 |
| CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model. | British journal of pharmacology 20100601 |
| Cannabinoid-1 receptor activation induces reactive oxygen species-dependent and -independent mitogen-activated protein kinase activation and cell death in human coronary artery endothelial cells. | British journal of pharmacology 20100601 |
| WIN55,212-2 induced deficits in spatial learning are mediated by cholinergic hypofunction. | Behavioural brain research 20100402 |
| CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes. | Cardiovascular research 20100301 |
| Ligand-induced regulation and localization of cannabinoid CB1 and dopamine D2L receptor heterodimers. | The Journal of pharmacology and experimental therapeutics 20100301 |
| Cannabinoid CB1 receptor facilitation of substance P release in the rat spinal cord, measured as neurokinin 1 receptor internalization. | The European journal of neuroscience 20100101 |
| Cannabinoid receptor type 1- and 2-mediated increase in cyclic AMP inhibits T cell receptor-triggered signaling. | The Journal of biological chemistry 20091218 |
| Effects of cannabinoids on caffeine contractures in slow and fast skeletal muscle fibers of the frog. | The Journal of membrane biology 20090501 |
| Sensitization of capsaicin-sensitive lung vagal afferents by anandamide in rats: role of transient receptor potential vanilloid 1 receptors. | Journal of applied physiology (Bethesda, Md. : 1985) 20090401 |
| Synthesis and pharmacological evaluation of coumarin derivatives as cannabinoid receptor antagonists and inverse agonists. | Bioorganic & medicinal chemistry 20090401 |
| Nicotine and Delta(9)-tetrahydrocannabinol withdrawal induce Narp in the central nucleus of the amygdala. | Synapse (New York, N.Y.) 20090301 |
| Delta9-tetrahydrocannabinol and cannabidiol modulate mitogen-induced tryptophan degradation and neopterin formation in peripheral blood mononuclear cells in vitro. | Journal of neuroimmunology 20090215 |
| Analogs of JHU75528, a PET ligand for imaging of cerebral cannabinoid receptors (CB1): development of ligands with optimized lipophilicity and binding affinity. | European journal of medicinal chemistry 20090201 |
| Tourette's syndrome. | Current topics in behavioral neurosciences 20090101 |
| Role of VR1 and CB1 receptors in modelling of cardio-respiratory response to arvanil, an endocannabinoid and vanilloid hybrid, in rats. | Life sciences 20080718 |
| Effects of the cannabinoid antagonist AM281 on systemic hemodynamics and mortality rate in streptozotocin-induced diabetic rats with endotoxic shock: comparison between non-diabetic and diabetic rats. | Acta anaesthesiologica Scandinavica 20080501 |
| Cannabinoids inhibit ATP-activated currents in rat trigeminal ganglionic neurons. | Sheng li xue bao : [Acta physiologica Sinica] 20071225 |
| The orphan receptor GPR55 is a novel cannabinoid receptor. | British journal of pharmacology 20071201 |
| Functional blockage of the cannabinoid receptor type 1 evokes a kappa-opiate-dependent analgesia. | Journal of neurochemistry 20071201 |
| Endocannabinoid signalling triggered by NMDA receptor-mediated calcium entry into rat hippocampal neurons. | The Journal of physiology 20071015 |
| Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicity. | Journal of the American College of Cardiology 20070807 |
| Endocannabinoid inhibition: a new cardioprotective strategy against doxorubicin cardiotoxicity. | Journal of the American College of Cardiology 20070807 |
| The synthetic cannabinoid HU210 induces spatial memory deficits and suppresses hippocampal firing rate in rats. | British journal of pharmacology 20070701 |
| Effects of cannabinoids on synaptic transmission in the frog neuromuscular junction. | The Journal of pharmacology and experimental therapeutics 20070501 |
| Interactions of cannabidiol with endocannabinoid signalling in hippocampal tissue. | The European journal of neuroscience 20070401 |
| Pharmacological characterization of receptor types mediating the dilator action of anandamide on blood vessels of the rat knee joint. | Life sciences 20070327 |
| Endocannabinoids mediate muscarine-induced synaptic depression at the vertebrate neuromuscular junction. | The European journal of neuroscience 20070301 |
| Endocannabinoids mediate the effects of acute stress and corticosterone on sex behavior. | Endocrinology 20070201 |
| Transcriptional regulation of the cannabinoid receptor type 1 gene in T cells by cannabinoids. | Journal of leukocyte biology 20070101 |
| Feasibility of central cannabinoid CB1 receptor imaging with [124I]AM281 PET demonstrated in a schizophrenic patient. | Psychiatry research 20061030 |
| Cannabinoid receptor-mediated inhibition of calcium signaling in rat retinal ganglion cells. | Molecular vision 20061006 |
| Protective activation of the endocannabinoid system during ischemia in dopamine neurons. | Neurobiology of disease 20061001 |
| Cannabidiol-induced intracellular Ca2+ elevations in hippocampal cells. | Neuropharmacology 20060401 |
| Role of phospholipase D2 in the agonist-induced and constitutive endocytosis of G-protein coupled receptors. | Journal of neurochemistry 20060401 |
| Constitutive activation drives compartment-selective endocytosis and axonal targeting of type 1 cannabinoid receptors. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20060322 |
| Therapeutic action of cannabinoid on axonal injury induced by peroxynitrite. | Brain research 20060303 |
| The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors. | European journal of pharmacology 20060215 |
| Effects of cannabinoids on the anxiety-like response in mice. | Pharmacological reports : PR 20060101 |
| Effects of AM281, a cannabinoid antagonist, on circulatory deterioration and cytokine production in an endotoxin shock model: comparison with norepinephrine. | Journal of anesthesia 20060101 |
| Cannabinoid antagonist AM 281 reduces mortality rate and neurologic dysfunction after cecal ligation and puncture in rats. | Critical care medicine 20051101 |
| Anti-inflammatory potential of CB1-mediated cAMP elevation in mast cells. | The Biochemical journal 20050601 |
| In vitro metabolism of diarylpyrazoles, a novel group of cannabinoid receptor ligands. | Drug metabolism and disposition: the biological fate of chemicals 20050401 |
| Developmental switch in synaptic mechanisms of hippocampal metabotropic glutamate receptor-dependent long-term depression. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20050316 |
| Effects of cannabinoids on nitric oxide production by chondrocytes and proteoglycan degradation in cartilage. | Biochemical pharmacology 20050215 |
| Inverse agonism and neutral antagonism at cannabinoid CB1 receptors. | Life sciences 20050204 |
| Effects of cannabinoids on colonic muscle contractility and tension in guinea pigs. | Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 20050201 |
| Blocking cannabinoid activation of FAK and ERK1/2 compromises synaptic integrity in hippocampus. | European journal of pharmacology 20050131 |
| Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M2-mediated direct suppression and M1/M3-mediated indirect suppression through endocannabinoid signalling. | The European journal of neuroscience 20040501 |
| Cannabinoid receptor activation in the rostral ventrolateral medulla oblongata evokes cardiorespiratory effects in anaesthetised rats. | British journal of pharmacology 20030901 |
| Cannabinoid CB1 receptor-mediated inhibition of glutamate release from rat hippocampal synaptosomes. | European journal of pharmacology 20030523 |
| Effects of cannabinoid receptor agonists on immunologically induced histamine release from rat peritoneal mast cells. | European journal of pharmacology 20030319 |
| Synthesis, structure-activity relationship, and evaluation of SR141716 analogues: development of central cannabinoid receptor ligands with lower lipophilicity. | Journal of medicinal chemistry 20030213 |
| Effect of cannabinoids on synaptic transmission in the rat hippocampal slice is temperature-dependent. | European journal of pharmacology 20020503 |
| Stimulation of pulmonary vagal C-fibres by anandamide in anaesthetized rats: role of vanilloid type 1 receptors. | The Journal of physiology 20020315 |
| Prevention of cannabinoid withdrawal syndrome by lithium: involvement of oxytocinergic neuronal activation. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20011215 |
| Long-term inhibition of nitric oxide synthase potentiates effects of anandamide in the rat mesenteric bed. | European journal of pharmacology 20010921 |
| CP55,940 increases intracellular Ca2+ levels in Madin-Darby canine kidney cells. | Life sciences 20010817 |
| Design and synthesis of the CB1 selective cannabinoid antagonist AM281: a potential human SPECT ligand. | AAPS pharmSci 19990601 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.